A double-blind, randomized, multicenter, and active treatment-controlled trial for efficacy and safety of cilostazol in acute ischemic stroke

Trial Profile

A double-blind, randomized, multicenter, and active treatment-controlled trial for efficacy and safety of cilostazol in acute ischemic stroke

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms CAIST
  • Most Recent Events

    • 01 Jul 2011 Results published in Cerebrovascular Diseases.
    • 22 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
    • 22 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top